Biopharm company raises $7M to support osteoporosis drug

Published Monday, June 2, 2014 11:00 am

Biopharm company raises $7M to support osteoporosis drug
In a private stock sale, Philadelphia-based Tarsa Therapeutics raised $7 million to support the filing of an application for a new drug. The drug, Ostora, is an experimental osteoporosis drug, and filing of the application is targeted for early 2015. Philadelphia Business Journal’s John George has the story.
Read the Full Story

Go back | Show other stories

NETWORKING OPPORTUNITIES

SPONSORSHIP OPPORTUNITIES

MEMBER NEWS

Hydration, Recovery & Summer Energy

Dehydration does not just affect athletes.

The True Cost of Healthcare: It’s More Than Premiums

The bigger, less obvious costs often go unmanaged.

Comcast Business to Host Evening Networking Event in May

This event is FREE to attend, but space is limited and RSVP is required to confirm attendance.

Main Line Health named healthcare provider for the 2026 PGA Championship

Main Line Health will deliver comprehensive on-site medical coverage throughout Championship Week.

MONTHLY NEWSLETTER